Posted by Michael Wonder on 10 Oct 2017
Cancer drug prices are at a tipping point
10 October 2017 - Cancer drugs generate a great deal of outrage with their six-figure price tags for vulnerable patients.
Until now, they've faced little in the way of price competition.That finally might be set to change with a recent wave of FDA approvals.
Despite having grown to become one of the largest categories of drugs, cancer medicines face relatively little price competition.
